Karyopharm Therapeutics
Joel DeVries is a Clinical Contracts Manager at Karyopharm Therapeutics Inc. since October 2018. Prior to that, Joel worked as an Investigator Pricing Analyst at ICON plc from February 2016 to October 2018 and as an Associate Investigator Grant Analyst at PPD from March 2014 to January 2016. Joel also has experience in the hospitality industry, having worked as a Manager/Bartender at Canyons of the Blue Ridge and as a Bartender at Macado's. Joel holds a Bachelor of Science in Business Administration with a focus on Finance and Banking/Risk Management and Insurance from Appalachian State University.
This person is not in any offices
Karyopharm Therapeutics
13 followers
Karyopharm Therapeutics Inc. (Nasdaq: KPTI) is an innovation-driven pharmaceutical company dedicated to the discovery, development, and commercialization of novel first-in-class drugs directed against nuclear export and related targets for the treatment of cancer and other major diseases. Karyopharm's Selective Inhibitor of Nuclear Export (SINE) compounds function by binding with and inhibiting the nuclear export protein XPO1 (or CRM1).